Skip to main content
An official website of the United States government

mtRTK inhibitor WM-S1-030

An orally bioavailable inhibitor of mutant receptor tyrosine kinase (mtRTK; pTyr-mtRTK), with potential antineoplastic activity. Upon oral administration, mtRTK inhibitor WM-S1-030 targets and binds to mtRTK, thereby inhibiting mtRTK-mediated signaling pathways. This inhibits proliferation of tumor cells expressing mtRTK.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:mutant receptor tyrosine kinase inhibitor WM-S1-030
Code name:WM-S1 030
WM-S1-030
WM-S1030
WMBIO
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search